4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-047437
Chairman and CEO bought 4,900 shares at an average $1.47 ($7,212)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-16 | Purchase | +1,000 | $1.50 | $1,500 | 10,793,871 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-19 | Purchase | +2,100 | $1.46 | $3,066 | 10,795,971 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-20 | Purchase | +1,800 | $1.47 | $2,646 | 10,797,771 | D |
| Open-market purchases · 4,900 sh · avg $1.47 · $7,212 | |||||||
Loading xslF345X03/doc4.xml…